<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940328-2-00064</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=94 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=50 g=1 f=1 -->   <USDEPT>DEPARTMENT OF JUSTICE</USDEPT>  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=1 -->  <USBUREAU>Drug Enforcement Administration</USBUREAU> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 --> Manufacturer of Controlled Substances; Application <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Pursuant to &sect;1301.43(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on January 25, 1994, Mallinckrodt Specialty Chemicals Company, Mallinckrodt &amp; Second Streets, St. Louis, Missouri 63147, made application to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below:  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <TABLE>  <!-- PJG tableformat 2,L2,tp0,i1,s25,xls36 -->  <!-- PJG ITAG l=95 g=1 f=1 --> &blank; <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Drug <!-- PJG 007 0150 intable --> 1Schedule <!-- PJG 007 0152 intable -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 --> Cocaine (9041) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Codeine (9050) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Diprenorphine (9058) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Etorphine Hydrochloride (9059) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Dihydrocodeine (9120) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Oxycodone (9143) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Hydromorphone (9150) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Diphenoxylate (9170) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Hydrocodone (9193) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Levorphanol (9220) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Meperidine (9230) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Methadone (9250) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Methadone-intermediate (9254) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Dextropropoxyphene, bulk (non-dosage forms) (9273) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Morphine (9300) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Thebaine (9333) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Opium extracts (9610) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Opium fluid extract (9620) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Opium tincture (9630) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Opium powdered (9639) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Opium granulated (9640) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Oxymorphone (9652) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Alfentanil (9737) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Sufentanil (9740) <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Fentanyl (9801) <!-- PJG 007 0104 intable --> II <!-- PJG /ITAG -->  </TABLE>  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the above application and may also file a written request for a hearing thereon in accordance with 21 CFR 1301.54 and in the form prescribed by 21 CFR 1316.47. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Any such comments, objections, or requests for a hearing may be addressed to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than April 27, 1994. <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: March 18, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Gene R. Haislip, <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;7167 Filed 3&hyph;25&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4410&hyph;09&hyph;M <!-- PJG /ITAG --> </BILLING>  <!-- PJG /STAG --></p>
		</main>
</body></html>
            